PUTRAJAYA, 20 May 2020 – The clinical research community in Malaysia celebrated Clinical Trials Day together with the rest of the world. This year, the celebration was done at a smaller scale to conform to social distancing and to avoid large gatherings amid the current COVID-19 outbreak. International Clinical Trials Day is celebrated around the world on May 20 every year to recognize the people who conduct clinical trials as well as the volunteers and patients who participate in it.
Clinical Trials Day has always been part of Clinical Research Malaysia’s (CRM) ongoing effort in creating awareness among the general public, patients as well as healthcare professionals that contribute to the development of better innovative treatments in the medical field.
To acknowledge the contribution of medical professionals in sponsored clinical research, a small presentation ceremony was held at the Ministry of Health complex in Putrajaya. The Minister of Health, YB Dato’ Sri Dr. Adham bin Baba, who is also the Chairman of CRM’s Board of Directors, presented the CRM Sponsored Research Award to five recipients in recognition of their significant contribution in clinical research, as well as to spur and encourage more of such efforts.
Clinicians who received the award include Dr. Voon Pei Jye (Medical Oncologist) from Hospital Umum Sarawak and Dr. Lily Wong (Haematologist) from Hospital Queen Elizabeth for contributing towards clinical trial patient recruitment and high numbers of new clinical trial uptake respectively. Hospital Sultan Ismail was recognized as the Clinical Trial Site of the Year for its significant growth in the number of sponsored research in 2019. Merck Sharp & Dohme (MSD), a multinational pharmaceutical company received Sponsor of the Year award for the highest number of new trials as well as highest cumulative study value in 2019, while IQVIA Malaysia received CRO of the Year award for the highest number of new clinical trial and trial sites initiated in 2019.
YB Dato’ Sri Dr. Adham stressed the importance of clinical trials to assess the safety and effectiveness of treatments. Malaysia has been a significant contributor in various drug and medical device clinical trials and the latest being the country’s involvement in the WHO Solidarity Trial to test several drugs in treating COVID-19. “Participation in clinical trials provides our patients with treatment options, especially those who have not responded well to the current standard of care or available treatment,” said Dr. Adham.